208 related articles for article (PubMed ID: 37047529)
61. A study of the molecular mechanism of quercetin and dasatinib combination as senolytic in alleviating age-related and kidney diseases.
Alharbi KS; Afzal O; Altamimi ASA; Almalki WH; Kazmi I; Al-Abbasi FA; Alzarea SI; Makeen HA; Albratty M
J Food Biochem; 2022 Dec; 46(12):e14471. PubMed ID: 36268851
[TBL] [Abstract][Full Text] [Related]
62. Eliminating senescent chondrogenic progenitor cells enhances chondrogenesis under intermittent hydrostatic pressure for the treatment of OA.
Dai H; Chen R; Gui C; Tao T; Ge Y; Zhao X; Qin R; Yao W; Gu S; Jiang Y; Gui J
Stem Cell Res Ther; 2020 May; 11(1):199. PubMed ID: 32450920
[TBL] [Abstract][Full Text] [Related]
63. Antiaging Vaccines Targeting Senescent Cells.
Mendelsohn AR; Larrick JW
Rejuvenation Res; 2022 Feb; 25(1):39-45. PubMed ID: 35081729
[TBL] [Abstract][Full Text] [Related]
64. Senolysis-Based Elimination of Chemotherapy-Induced Senescent Breast Cancer Cells by Quercetin Derivative with Blocked Hydroxy Groups.
Lewińska A; Przybylski P; Adamczyk-Grochala J; Błoniarz D; Litwinienko G; Wnuk M
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158873
[TBL] [Abstract][Full Text] [Related]
65. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
[TBL] [Abstract][Full Text] [Related]
66. From the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs.
L'Hôte V; Mann C; Thuret JY
Open Biol; 2022 Sep; 12(9):220171. PubMed ID: 36128715
[TBL] [Abstract][Full Text] [Related]
67. Anti-Aging Effects of Anthocyanin Extracts of
Hu X; Yang Y; Tang S; Chen Q; Zhang M; Ma J; Qin J; Yu H
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675036
[TBL] [Abstract][Full Text] [Related]
68. Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer.
Troiani M; Colucci M; D'Ambrosio M; Guccini I; Pasquini E; Varesi A; Valdata A; Mosole S; Revandkar A; Attanasio G; Rinaldi A; Rinaldi A; Bolis M; Cippà P; Alimonti A
Nat Commun; 2022 Apr; 13(1):2177. PubMed ID: 35449130
[TBL] [Abstract][Full Text] [Related]
69. Anti-senescence compounds: A potential nutraceutical approach to healthy aging.
Gurău F; Baldoni S; Prattichizzo F; Espinosa E; Amenta F; Procopio AD; Albertini MC; Bonafè M; Olivieri F
Ageing Res Rev; 2018 Sep; 46():14-31. PubMed ID: 29742452
[TBL] [Abstract][Full Text] [Related]
70. The Ercc
Wong A; Kieu T; Robbins PD
Aging (Albany NY); 2020 Dec; 12(24):24481-24483. PubMed ID: 33353886
[TBL] [Abstract][Full Text] [Related]
71. Cellular senescence in aging and age-related diseases: Implications for neurodegenerative diseases.
Wissler Gerdes EO; Zhu Y; Weigand BM; Tripathi U; Burns TC; Tchkonia T; Kirkland JL
Int Rev Neurobiol; 2020; 155():203-234. PubMed ID: 32854855
[TBL] [Abstract][Full Text] [Related]
72. IGFBP-3 plays an important role in senescence as an aging marker.
Hong S; Kim MM
Environ Toxicol Pharmacol; 2018 Apr; 59():138-145. PubMed ID: 29579543
[TBL] [Abstract][Full Text] [Related]
73. A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses.
Bent EH; Gilbert LA; Hemann MT
Genes Dev; 2016 Aug; 30(16):1811-21. PubMed ID: 27566778
[TBL] [Abstract][Full Text] [Related]
74. Targeting cellular senescence based on interorganelle communication, multilevel proteostasis, and metabolic control.
Cavinato M; Madreiter-Sokolowski CT; Büttner S; Schosserer M; Zwerschke W; Wedel S; Grillari J; Graier WF; Jansen-Dürr P
FEBS J; 2021 Jun; 288(12):3834-3854. PubMed ID: 33200494
[TBL] [Abstract][Full Text] [Related]
75. Treatment with the BCL-2/BCL-xL inhibitor senolytic drug ABT263/Navitoclax improves functional hyperemia in aged mice.
Tarantini S; Balasubramanian P; Delfavero J; Csipo T; Yabluchanskiy A; Kiss T; Nyúl-Tóth Á; Mukli P; Toth P; Ahire C; Ungvari A; Benyo Z; Csiszar A; Ungvari Z
Geroscience; 2021 Oct; 43(5):2427-2440. PubMed ID: 34427858
[TBL] [Abstract][Full Text] [Related]
76. The Senolytic Drug Fisetin Attenuates Bone Degeneration in the
Hambright WS; Mu X; Gao X; Guo P; Kawakami Y; Mitchell J; Mullen M; Nelson AL; Bahney C; Nishimura H; Hellwinkel J; Eck A; Huard J
J Osteoporos; 2023; 2023():5572754. PubMed ID: 36875869
[TBL] [Abstract][Full Text] [Related]
77. Pan-mTOR inhibitors sensitize the senolytic activity of navitoclax via mTORC2 inhibition-mediated apoptotic signaling.
Xu W; Zhao T; Chen H; Huang N; Gong H; Zhang J; Yang Y; Li T; Zhang G; Gong C; Yang M; Xiao H
Biochem Pharmacol; 2022 Jun; 200():115045. PubMed ID: 35439535
[TBL] [Abstract][Full Text] [Related]
78. Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools.
Knoppert SN; Valentijn FA; Nguyen TQ; Goldschmeding R; Falke LL
Front Pharmacol; 2019; 10():770. PubMed ID: 31354486
[TBL] [Abstract][Full Text] [Related]
79. Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice.
Roos CM; Zhang B; Palmer AK; Ogrodnik MB; Pirtskhalava T; Thalji NM; Hagler M; Jurk D; Smith LA; Casaclang-Verzosa G; Zhu Y; Schafer MJ; Tchkonia T; Kirkland JL; Miller JD
Aging Cell; 2016 Oct; 15(5):973-7. PubMed ID: 26864908
[TBL] [Abstract][Full Text] [Related]
80. Pleiotropic Effects of Tocotrienols and Quercetin on Cellular Senescence: Introducing the Perspective of Senolytic Effects of Phytochemicals.
Malavolta M; Pierpaoli E; Giacconi R; Costarelli L; Piacenza F; Basso A; Cardelli M; Provinciali M
Curr Drug Targets; 2016; 17(4):447-59. PubMed ID: 26343116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
